Cargando…
In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147
CD44 and CD147 are associated with cancer metastasis and progression. Our purpose in the study was to investigate the effects of down-regulation of CD44 or CD147 on the metastatic ability of prostate cancer (CaP) cells, their docetaxel (DTX) responsiveness and potential mechanisms involved in vitro...
Autores principales: | Hao, Jingli, Madigan, Michele C., Khatri, Aparajita, Power, Carl A., Hung, Tzong-Tyng, Beretov, Julia, Chang, Lei, Xiao, Weiwei, Cozzi, Paul J., Graham, Peter H., Kearsley, John H., Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411712/ https://www.ncbi.nlm.nih.gov/pubmed/22870202 http://dx.doi.org/10.1371/journal.pone.0040716 |
Ejemplares similares
-
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
por: Hao, J, et al.
Publicado: (2010) -
Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
por: Pinheiro, Céline, et al.
Publicado: (2010) -
CD147 mediates the CD44s-dependent differentiation of myofibroblasts driven by transforming growth factor-β(1)
por: Woods, Emma L., et al.
Publicado: (2021) -
Expression of COX-2, CD44v6 and CD147 and Relationship with Invasion and Lymph Node Metastasis in Hypopharyngeal Squamous Cell Carcinoma
por: Yang, Qing, et al.
Publicado: (2013) -
Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance
por: Wang, Xiaohong, et al.
Publicado: (2020)